Diabetic nephropathy (DN) is one of the main complications of diabetes and a major cause
of end-stage renal disease, which has a severe impact on the quality of life of patients. Strict …

Background: Metabolomics is useful in elucidating the progression of diabetes; however, the
follow-up changes in metabolomics among health, diabetes mellitus, and diabetic kidney …

Aims Metabolomics have been used to evaluate the role of small molecules in human
disease. However, the cost and complexity of the methodology and interpretation of findings …

With the increasing incidence of diabetes, diabetic kidney disease has become a major
cause of chronic kidney disease. The role of the gut microbiota in diabetes and its related …

Introduction: Metabolomics could offer novel prognostic biomarkers and elucidate
mechanisms of diabetic kidney disease (DKD) progression. Via metabolomic analysis of …

Purpose Diabetic kidney disease (DKD) is the most common complication of type 2 diabetes
mellitus (T2DM), and its pathogenesis is not yet fully understood and lacks noninvasive and …

Diabetic kidney disease (DKD) is a prevailing complication arising from diabetes mellitus.
Unfortunately, there are no trustworthy and efficacious treatment modalities currently …

Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …

Diabetic kidney disease (DKD) represents a growing public health burden and is the leading
cause of end-stage kidney diseases. In recent years, host-gut microbiota interactions have …

Background: Diabetic kidney disease (DKD) is an increasing health problem and an extra
burden to health services. The study of characteristic metabolic alterations of DKD is crucial …